• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
Catholic Review

Catholic Review

Inspiring the Archdiocese of Baltimore

Menu
  • Home
  • News
        • Local News
        • World News
        • Vatican News
        • Obituaries
        • Featured Video
        • En Español
        • Sports News
        • Official Clergy Assignments
        • Schools News
  • Commentary
        • Contributors
          • Question Corner
          • George Weigel
          • Elizabeth Scalia
          • Michael R. Heinlein
          • Effie Caldarola
          • Guest Commentary
        • CR Columnists
          • Archbishop William E. Lori
          • Rita Buettner
          • Christopher Gunty
          • George Matysek Jr.
          • Mark Viviano
          • Father Joseph Breighner
          • Father Collin Poston
          • Amen Columns
  • Entertainment
        • Events
        • Movie & Television Reviews
        • Arts & Culture
        • Books
        • Recipes
        • CR Kids
  • About Us
        • Contact Us
        • Our History
        • Meet Our Staff
        • Photos to own
        • Shop
        • CR Media platforms
        • Electronic Edition
        • Subscribe
  • Advertising
  • Kids
  • News Tips
  • Radio/Podcasts
        • Catholic Review Radio
        • Protagonistas de Fe
        • In God’s Image
        • “In Charity and Truth” with Archbishop William E. Lori
  • Subscribe
Mifepristone, the first medication in a two-drug regimen used for early abortion and more recently for early miscarriage care, is prepared for a patient at Alamo Women's Clinic in Carbondale, Ill., April 20, 2023. Representatives of Walgreens and CVS announced March 1 their pharmacies will begin dispensing mifepristone in select states where both abortion and pharmacy distribution of the drug is legal. (OSV News photo/Evelyn Hockstein, Reuters)

Walgreens, CVS pharmacies to begin dispensing pills used for abortion, early miscarriage

March 2, 2024
By Gina Christian
OSV News
Filed Under: Feature, News, Respect Life, World News

Two major U.S. pharmacy chains have announced they will begin dispensing the drug mifepristone, which has been prescribed for both abortion and early miscarriage, within the coming days.

Representatives of Walgreens and CVS announced the move March 1 in an interview with The New York Times.

Walgreens also issued a press release the same day, stating that it “expects to begin dispensing within a week, consistent with federal and state laws” in a “phased rollout in select locations to allow us to ensure quality, safety, and privacy for our patients, providers, and team members.”

Both pharmacy chains have received certification from the U.S. Food and Drug Administration to supply the drug under guidelines the agency issued last year. At present, the chains will only provide mifepristone in person, not by mail, in select states where both abortion and pharmacy distribution of abortion drugs is legal.

A synthetic steroid, mifepristone — introduced 20 years ago — works by blocking the hormone progesterone, which is necessary for pregnancy to continue. When used in combination with misoprostol, which causes contractions, it induces a “medication abortion” up to 10 weeks into a pregnancy. This regimen is now used for more than half of U.S. abortions, according to the abortion research firm Guttmacher Institute.

However, the same pills are also now prescribed to women who experience early pregnancy miscarriage in order to expel any fetal remains and residual pregnancy tissue from the womb. While misoprostol has been prescribed alone by OB-GYNs, the American College of Obstetricians and Gynecologists recently updated its protocols to recommend a combination of mifepristone and misoprostol as more effective than misoprostol alone for early miscarriage care based on research published since 2018.

According to the National Library of Medicine, an estimated 26 percent of all pregnancies, and up to 10 percent of clinically recognized pregnancies, end in miscarriage, the loss of pregnancy less than 20-weeks gestation.

Because the Catholic Church teaches that all human life is sacred and must be respected from conception to natural death, it opposes the use of medicine when it is intended to cause direct abortion, which takes the life of the unborn child. However, the church also does not oppose the use of medicine when it is intended for restoring the body to health or life, which it calls “precious gifts entrusted to us by God.”

Walgreens plans to offer the mifepristone in select pharmacies in California, Illinois, Massachusetts, New York and Pennsylvania, while CVS will distribute the drug in all of its Massachusetts and Rhode Island pharmacies.

In a March 1 statement, President Joe Biden called the pharmacy chains’ announcement “an important milestone in ensuring access to mifepristone,” and encouraged “all pharmacies that want to pursue this option to seek (FDA) certification” to do so.

However, in a press release issued the same day, Susan B. Anthony Pro-Life America lambasted the move, citing mifepristone’s longstanding, morally illicit usage for early abortion.

“As two of the world’s largest, most trusted ‘health’ brands, the decision by CVS and Walgreens to sell dangerous abortion drugs is shameful, and the harm to unborn babies and their mothers incalculable,” Kate Daniel, SBA Pro-Life America’s state policy director, said.

Daniel accused the Biden administration of “pushing to turn every pharmacy and post office in America into an abortion center for the sake of abortion industry greed,” claiming the FDA under Democratic presidents has “illegally rolled back basic safety standards, like in-person doctor visits, even allowing these deadly drugs to be sent through the mail.”

Daniel noted the Supreme Court will hear oral arguments March 26 for FDA v. Alliance for Hippocratic Medicine and Danco v. Alliance for Hippocratic Medicine, which involve legal challenges to the FDA’s regulatory approval of mifepristone.

Read More Respect Life

Housing, gender, abortion policies among state ballot measures in 2026

Cardinal Cupich, women religious, Catholic pharmacist sue Illinois over assisted suicide law

Scottish school settles case with Catholic teacher fired after abortion discussion

Cassidy takes aim at FDA mifepristone regulation, manufacturers

Catholic End-of-Life Conference coming to Clarksville

The abnormal abortion

Copyright © 2024 OSV News

Print Print

Primary Sidebar

Gina Christian

Click here to view all posts from this author

For the latest news delivered twice a week via email or text message, sign up to receive our free enewsletter.

| MOST POPULAR |

  • Betty Contino, a giant in empowering Baltimore’s Catholic school students, dies at 81
  • Relics of St. Bernadette will come to Archdiocese of Baltimore in late September
  • Victim 0001: Friends recall Father Mychal Judge’s 9/11 loss and legacy
  • Black Catholics need stronger voice in Catholic Church, Bishop Boxie says
  • 9/11 a generation later 

| Latest Local News |

Archbishop Lori offers prayers on 25th anniversary of 9/11 attacks

Relics of St. Bernadette will come to Archdiocese of Baltimore in late September

Second annual ‘Saints on Their Way’ festival set for Sept. 12-13 in Emmitsburg

Priests connected to Archdiocese of Baltimore were on the front lines on 9/11

9/11 a generation later 

| Latest World News |

Pope aims to help Europe find ‘new momentum’ with France trip, says postulator of Schuman cause

US pilgrims are already gearing up for World Youth Day 2027 in South Korea

Mozambique bishops say questions remain unanswered 3 months after bishop’s murder

Minnesota Supreme Court hears case over former employee’s challenge to Catholic school gender policy

US bishops urge Trump administration to end mass deportations of Haitians

| Catholic Review Radio |

Footer

Our Vision

Real Life. Real Faith. 

Catholic Review Media communicates the Gospel and its impact on people’s lives in the Archdiocese of Baltimore and beyond.

Our Mission

Catholic Review Media provides intergenerational communications that inform, teach, inspire and engage Catholics and all of good will in the mission of Christ through diverse forms of media.

Contact

Catholic Review
320 Cathedral Street
Baltimore, MD 21201
443-524-3150
mail@CatholicReview.org

 

Social Media

  • Facebook
  • Instagram
  • Twitter
  • YouTube

Recent

  • Pope aims to help Europe find ‘new momentum’ with France trip, says postulator of Schuman cause
  • US pilgrims are already gearing up for World Youth Day 2027 in South Korea
  • Archbishop Lori offers prayers on 25th anniversary of 9/11 attacks
  • Mozambique bishops say questions remain unanswered 3 months after bishop’s murder
  • Minnesota Supreme Court hears case over former employee’s challenge to Catholic school gender policy
  • US bishops urge Trump administration to end mass deportations of Haitians
  • At vigil Mass on eve of 9/11, New York archbishop emphasizes healing, peace
  • Black Catholics need stronger voice in Catholic Church, Bishop Boxie says
  • Indianapolis archbishop grants Mass dispensation amid ICE detention fears

Search

Membership

Catholic Media Assocation

Maryland-Delaware-DC Press Association

The Associated Church Press

© 2026 CATHOLIC REVIEW MEDIA, ALL RIGHTS RESERVED